Janney Montgomery Scott LLC lessened its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 2.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,413 shares of the company’s stock after selling 750 shares during the quarter. Janney Montgomery Scott LLC’s holdings in BlackRock Health Sciences Term Trust were worth $419,000 as of its most recent SEC filing.
Several other large investors also recently made changes to their positions in BMEZ. Royal Bank of Canada lifted its holdings in BlackRock Health Sciences Term Trust by 326.9% during the 1st quarter. Royal Bank of Canada now owns 1,594,157 shares of the company’s stock valued at $23,753,000 after purchasing an additional 1,220,764 shares during the last quarter. Penserra Capital Management LLC lifted its holdings in BlackRock Health Sciences Term Trust by 7.8% during the 1st quarter. Penserra Capital Management LLC now owns 1,122,813 shares of the company’s stock valued at $16,729,000 after purchasing an additional 81,010 shares during the last quarter. Absolute Investment Advisers LLC lifted its holdings in BlackRock Health Sciences Term Trust by 112.7% during the 1st quarter. Absolute Investment Advisers LLC now owns 582,256 shares of the company’s stock valued at $8,676,000 after purchasing an additional 308,562 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its holdings in BlackRock Health Sciences Term Trust by 2.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 302,049 shares of the company’s stock valued at $4,501,000 after purchasing an additional 6,458 shares during the last quarter. Finally, Quarry LP lifted its holdings in BlackRock Health Sciences Term Trust by 102.6% during the 1st quarter. Quarry LP now owns 222,175 shares of the company’s stock valued at $3,310,000 after purchasing an additional 112,514 shares during the last quarter.
BlackRock Health Sciences Term Trust Stock Up 0.0%
Shares of BlackRock Health Sciences Term Trust stock opened at $14.87 on Friday. The business has a fifty day simple moving average of $14.41 and a two-hundred day simple moving average of $14.28. BlackRock Health Sciences Term Trust has a 1 year low of $12.58 and a 1 year high of $16.75.
BlackRock Health Sciences Term Trust Dividend Announcement
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Read More
- Five stocks we like better than BlackRock Health Sciences Term Trust
- How to Short a Stock in 5 Easy Steps
- Johnson & Johnson’s M&A Strategy Is the Real Story for Investors
- The How And Why of Investing in Oil Stocks
- Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?
- Where to Find Earnings Call Transcripts
- Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.